AI assistant
Sending…
Milestone Pharmaceuticals Inc. — Director's Dealing 2020
Oct 5, 2020
9643_dirs_2020-10-05_8d8b0fb8-f504-48db-b335-b8f9695a33a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2020-10-01
Reporting Person: Giles Lisa M. (Director)
More from Milestone Pharmaceuticals Inc.
Capital/Financing Update
2026
May 13
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 20
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5